Efficacy of the Extracorporeal Shock Wave Therapy in Athletes With Patellar Tendinopathy

Last updated: January 29, 2025
Sponsor: Ahi Evran University Education and Research Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Tendon Injuries

Sprains

Treatment

ESWT (Extracorporeal Shock Wave Therapy)

Eccentric exercise program (EEP)

Clinical Study ID

NCT06705881
2024/1012
  • Ages 18-65
  • All Genders

Study Summary

The aim of this study is to investigate the effectiveness of extracorporeal shock wave therapy (ESWT) in addition to eccentric exercise on the clinical outcomes of PT in the treatment of athletes with patellar tendinopathy (PT). Participants will be randomly divided into two groups. The intervention group will receive focus ESWT 3 times a week in addition to 6 weeks of exercise. The control group will be given 6 weeks of exercise. Evaluations will be made at the 3rd and 6th weeks, and at the 3rd, 6th and 12th months. Patient evaluation will begin with obtaining sociodemographic information. Patients' pain level will be assessed using visual analog scale (VAS), tendon pain and function VISA-P, functional capacity; The patients will be assessed with the maximal vertical jump test (MDS), single leg jump distance test (SLHD), single leg squat test (STS) on the incline board, pain catastrophe with the pain catastrophe scale (PCS), kinesiophobia with the Tampa Kinesiophobia Scale (TKS), quality of life short form-12 (SF-12) and physical activity level with the Tegner Activity Scale (TAS).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Localized pain in the inferior pole of the patella during single-leg squatting dueto load,

  • Pain or tenderness with palpation of the patellar tendon,

  • Complaints of pain in the patellar tendon due to training, competition or physicalactivity in the last 6 months,

  • Performing sports/physical activities related to jumping and landing,

  • Professional and recreational athletes who perform at least 5 and above according tothe Tegner Activity score,

  • VISA-P scale score <80 out of 100.

Exclusion

Exclusion Criteria:

  • Presence of other knee pathologies,

  • Known presence of inflammatory joint diseases or familial hypercholesterolemia,

  • Daily use of drugs with presumed effects on the patellar tendon (e.g.fluoroquinolones) in the last 12 months,

  • Local injection therapy with corticosteroids in the last 12 months,

  • Previous patellar tendon rupture,

  • Any lower extremity surgery in the last 6 months.

Study Design

Total Participants: 32
Treatment Group(s): 2
Primary Treatment: ESWT (Extracorporeal Shock Wave Therapy)
Phase:
Study Start date:
December 01, 2024
Estimated Completion Date:
September 01, 2025

Connect with a study center

  • Ahi Evran University

    Kırşehir, Center 40100
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.